PharmaShots | Incisive News in 3 Shots

Subscribe Now

Chronic Hepatitis C

Gilead's Epclusa (Sofosbuvir/Velpatasvir) Receives the US FDA's Approval for Children with Chronic Hepatitis C Infection

Gilead's Epclusa (Sofosbuvir/Velpatasvir) Receives the US FDA's Approval for Children with Chronic Hepatitis C Infection

March 20, 2020

AbbVie's Mavyret (glecaprevir/pibrentasvir) Receives FDA's Approval for its Expanded Indication in Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis Across All Genot

AbbVie's Mavyret (glecaprevir/pibrentasvir) Receives FDA's Approval for its Expanded Indication in Treatment-Naïve Patients with C...

September 27, 2019

Gilead's subsidiary Asegua Therapeutics Plans to Launch Authorized Generic Versions in the US of Epclusa & Harvoni for the Treatment of Chronic Hepatitis C

Gilead's subsidiary Asegua Therapeutics Plans to Launch Authorized Generic Versions in the US of Epclusa & Harvoni for the Tre...

September 24, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us